Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
circRNF220
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factor
Not available
Downstream target
miR-30a/MYSM1/IER2
Differential expression in
recurrence vs. nonrecurrence
Not available
Cancer name
Pediatric Acute Myeloid Leukemia
Alias
Leukemia
Cancer site
Leukemia
Recurrence type
Recurrence
Overall survival rate of patients with
high ncRNA expression
Not available
ncRNA differential expression in
cancer
patients vs. health people
Up
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
Recurrence patients
Not available
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
these findings demonstrated that circRNF220 could be highly efficient and specific for the accurate diagnosis of pediatric AML, with implications for relapse prediction
Tissue resource
human leukemia cell lines K562
human embryonic kidney cell lines HEK-293T
bone marrow and peripheral blood samples from pediatric patients
human leukemia cell lines HL-60
human leukemia cell lines THP-1
Experiment
qRT-PCR
Institute
American Type Culture Collection
American Type Culture Collection
Guangzhou Women and Children's Medical Center of Guangzhou Medical University
American Type Culture Collection
American Type Culture Collection
Country
USA
USA
China
USA
USA
Continent
North American
North American
Asia
North American
North American
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.